Sisätautien yksikkö
Department of Internal Medicine

Julkaisut 2009
Publications 2009

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Ahonen T et al. Gender differences relating to metabolic syndrome and proinflammation in Finnish subjects with elevated blood pressure.
2 Astrup A et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.
3 Boesgaard TW et al. Variant near ADAMTS9 known to associate with type 2 diabetes is related to insulin resistance in offspring of type 2 diabetes patients-EUGENE2 study.
4 De Mello VDF et al. Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease.
5 de Rooij SR et al. Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study.
6 de Rooij SR et al. Low-grade chronic inflammation in the relationship between insulin sensitivity and cardiovascular disease (RISC) population: associations with insulin resistance and cardiometabolic risk profile.
7 Gastaldelli A et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population.
8 Groop PH et al. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes.
9 Gylling H et al. The metabolism of plant sterols is disturbed in postmenopausal women with coronary artery disease.
10 Haukkamaa L et al. Pre-eclampsia is a risk factor of carotid artery atherosclerosis.
11 Hedman M et al. Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer.
12 Heikkinen S et al. The Pro12Ala PPARgamma2 variant determines metabolism at the gene-environment interface.
13 Heinonen MV et al. Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome.
14 Hintikka J et al. Unemployment and ill health: a connection through inflammation?
15 Hintikka J et al. Hypogonadism, decreased sexual desire, and long-term depression in middle-aged men.
16 Honka M-J et al. The Pro12Ala polymorphism of the PPARgamma2 gene is associated with hepatic glucose uptake during hyperinsulinwmia in subjects with type 2 diabetes mellitus.
17 Huikuri HV et al. Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction.
18 Hämäläinen S. Severe Sepsis in Neutropenic Haematological Patients.
19 Hämäläinen S et al. Serum vascular endothelial growth factor in adult haematological patients with neutropenic fever: a comparison with C-reactive protein.
20 Hämäläinen S et al. Severe sepsis in autologous stem cell transplant recipients: Microbiological aetiology, risk factors and outcome.
21 Jokinen JJ et al. Pacemaker therapy after tricuspid valve operations: implications on mortality, morbidity, and quality of life.
22 Jons C et al. The Medical ANtiarrhytmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) Trial: clinical rationale,study design, and implementation.
23 Kaipiainen-Seppänen O et al. Podofyllotoksiinia sisältävän solunsalpaajavalmisteen ja simvastatiinin lihashaitat.
24 Kalesnykiene V et al. The effect of glycaemic control on the quantitative characteristics of retinopathy lesions in patients with type 2 diabetes mellitus: 10-year follow-up study.
25 Kathiresan S et al. Common variants at 30 loci contribute to polygenic dyslipidemia.
26 Kaunisto MA et al. Elevated MBL concentrations are not an indication of association between the MBL2 gene and type 1 diabetes or diabetic nephropathy.
27 Kilhovd BK et al. Increased serum levels of methylglyoxal-derived hydroimidazolone-AGE are associated with increased cardiovascular disease mortality in nondiabetic women.
28 Kong A et al. Parental origin of sequence variants associated with complex diseases.
29 Koukkunen H et al. Vanhusten sepelvaltimotauti kuormittaa mmerkittävästi terveydenhoitojärjestelmää.
30 Koutnikova H et al. Identification of the UBP1 locus as a critical blood pressure determinant using a combination of mouse and human genetics.
31 Laakso M. Not for the eyes only: PAX6 and glucose metabolism.
32 Laakso M. Natural history of type 2 diabetes and macrovascular disease.
33 Laakso M. Endokriinisten sairauksien geenidiagnostiikka.
34 Langenberg C et al. Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response.
35 Lappalainen S et al. Genetic variation of FTO and TCF7L2 in premature adrenarche.
36 Li X et al. Additive effects of genetic variation in GCK and G6PC2 on insulin secretion and fasting glucose.
37 Lindgren CM et al. Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution.
38 Lundell L et al. Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis.
39 Luotola K et al. Association of variation in the Interleukin-1 gene family with diabetes and glucose homeostasis.
40 Lyssenko V et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion.
41 Meex SJR et al. The ATF6-Met[67]Val substitution is associated with increased plasma cholesterol levels.
42 Moya A et al. Guidelines for the diagnosis and management of syncope (version 2009): the Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC).
43 Mustonen P et al. Sydänpotilaan antitromboottinen lääkitys leikkausten ja pientoimenpiteiden yhteydessä.
44 Mäntyselkä P et al. Persistent pain at multiple sites - connection to glucose derangement.
45 Müssig K et al. Association of common genetic variation in the FOXO1 gene with beta-cell dysfunction, impaired glucose tolerance, and type 2 diabetes.
46 Newton-Cheh C et al. Genome-wide association study identifies eight loci associated with blood pressure.
47 Niskanen L et al. Fasting plasma glucose variability as a marker of nocturnal hypoglycemia in diabetes: evidence from the PREDICTIVE study.
48 Nymark M et al. Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes.
49 Plaisier CL et al. Galanin preproprotein is associated with elevated plasma triglycerides.
50 Prokopenko I et al. Variants in MTNR1B influence fasting glucose levels.
51 Pulizzi N et al. Interaction between prenatal growth and high-risk genotypes in the development of type 2 diabetes.
52 Rajamani K et al. Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial.
53 Riikola A et al. Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey.
54 Ristikankare M et al. Cardiac autonomic regulation during gastroscopy.
55 Rosengård-Bärlund M et al. Early autonomic dysfunction in type 1 diabetes: a reversible disorder?
56 Rutanen J. Genetic Regulation of Energy Homeostasis and Obesity. Studies on Genes Encoding Sirtuin 1, Melanocortin Receptors.
57 Salanti G et al. Underlying genetic models of inheritance in established type 2 diabetes associations.
58 Salopuro T et al. Variation in the UCP2 and UCP3 genes associates with abdominal obesity and serum lipids: The Finnish daibetes prevention study.
59 Savolainen E et al. Prevalence of antibodies against Chlamydia trachomatis and incidence of C. trachomatis-induced reactive arthritis in an early arthritis series in Finland in 2000.
60 Schwartz GG et al. Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.
61 Sipilä K et al. Metabolic syndrome and carotid intima media thickness in the Health 2000 Survey.
62 Stancáková A et al. Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men.
63 Stancáková A et al. Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men.
64 Thorn LM et al. Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes.
65 Tiihonen J et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).
66 Turpeinen AK et al. Cardiac sympathetic activity is associated with inflammation and neurohumoral activation in patients with idiopathic dilated cardiomyopathy.
67 Valtonen M et al. Leisure-time physical activity, cardiorespiratory fitness and feelings of hopelessness in men.
68 Viinamäki H et al. Association of depressive symptoms and metabolic syndrome in men.
69 Virkamäki A, Niskanen L. Diabetes.
70 Wadén J et al. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.
71 Wadén J et al. Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial.
72 Weyrich P et al. Common polymorphisms within the NR4A3 locus, encoding the orphan nuclear receptor Nor-1, are associated with enhanced beta-cell function in non-diabetic subjects.
73 Willer CJ et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation.
74 Ylinen E-R et al. Medication-free colonoscopy - factors related to pain and its assessment.

Sisätautien yksikkö Department of Internal Medicine
Julkaisutietokanta 27.5.2010 Publications Data Base 27.5.2010